Incidence of herpes zoster, before and after varicella-vaccination-associated decreases in the incidence of varicella, 1992-2002

被引:198
作者
Jumaan, AO
Yu, OC
Jackson, LA
Bohlke, K
Galil, K
Seward, JF
机构
[1] Ctr Dis Control & Prevent, Atlanta, GA USA
[2] Grp Hlth Cooperat Puget Sound, Seattle, WA USA
[3] Cubist Pharmaceut, Lexington, MA USA
关键词
D O I
10.1086/430325
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Varicella zoster virus (VZV) causes varicella and, later in the life of the host, may reactivate to cause herpes zoster (HZ). Because it is hypothesized that exposure to varicella may boost immunity to latent VZV, the vaccination-associated decrease in varicella disease has led some to suggest that the incidence of HZ might increase. We assessed the impact that varicella vaccination has on the incidence of varicella and of HZ. Methods. Codes for cases of varicella and of HZ in an HMO were determined in automated databases of inpatients and outpatients, on the basis of the Ninth Revision of the International Classification of Diseases. We calculated the incidence, during 1992 - 2002, of varicella and of HZ. Results. The incidence of HZ remained stable as the incidence of varicella decreased. Age-adjusted and - specific annual incidence rates of varicella decreased steadily, starting with 1999. The age-adjusted rates decreased from 2.63 cases/1000 person-years during 1995 to 0.92 cases/1000 person- years during 2002; among children 1 - 4 years old, there was a 75% decrease between 1992 - 1996 and 2002. Age-adjusted and - specific annual incidence rates of HZ fluctuated slightly over time; the age-adjusted rate was highest, at 4.05 cases/1000 person-years, in 1992, and was 3.71 cases/ 1000 person- years in 2002. Conclusions. Our findings revealed that the vaccination-associated decrease in varicella disease did not result in an increase in the incidence of HZ. These early findings will have to be confirmed as the incidence of varicella disease continues to decrease.
引用
收藏
页码:2002 / 2007
页数:6
相关论文
共 33 条
[1]  
[Anonymous], POP PROF US 2000
[2]   IMMUNOLOGICAL EVIDENCE OF REINFECTION WITH VARICELLA-ZOSTER VIRUS [J].
ARVIN, AM ;
KOROPCHAK, CM ;
WITTEK, AE .
JOURNAL OF INFECTIOUS DISEASES, 1983, 148 (02) :200-205
[3]   Varicella vaccine and shingles [J].
Brisson, M ;
Edmunds, WJ ;
Gay, NJ ;
Miller, E .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (17) :2211-2211
[4]   Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox [J].
Brisson, M ;
Gay, NJ ;
Edmunds, WJ ;
Andrews, NJ .
VACCINE, 2002, 20 (19-20) :2500-2507
[5]   Modelling the impact of immunization on the epidemiology of varicella zoster virus [J].
Brisson, M ;
Edmunds, WJ ;
Gay, NJ ;
Law, B ;
De Serres, G .
EPIDEMIOLOGY AND INFECTION, 2000, 125 (03) :651-669
[6]  
*CDC, 2003, MMWR-MORBID MORTAL W, V52, P884
[7]  
*CDCP NAT IMM PROG, 2002, EST VACC COV IND VAC
[8]   Characteristics of patients with herpes zoster on presentation to practitioners in France [J].
Chidiac, C ;
Bruxelle, J ;
Daures, JP ;
Xuan, TH ;
Morel, P ;
Leplège, A ;
El Hasnaoui, A ;
de Labareyre, C .
CLINICAL INFECTIOUS DISEASES, 2001, 33 (01) :62-69
[9]   THE INCIDENCE OF HERPES-ZOSTER [J].
DONAHUE, JG ;
CHOO, PW ;
MANSON, JE ;
PLATT, R .
ARCHIVES OF INTERNAL MEDICINE, 1995, 155 (15) :1605-1609
[10]   Acute pain in herpes zoster: the famciclovir database project [J].
Dworkin, RH ;
Nagasako, EM ;
Johnson, RW ;
Griffin, DRJ .
PAIN, 2001, 94 (01) :113-119